"After billions of doses, we now have an extraordinary amount of scientific evidence." The post Huge Survey Finds the Truth ...

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

Shares of Moderna MRNA have surged 33.5% over the past week, adding nearly $8 billion to the company's market value. The ...

Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) ...

CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...

In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...